These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22414066)

  • 1. Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America.
    Bartoloni A; Pallecchi L; Riccobono E; Mantella A; Magnelli D; Di Maggio T; Villagran AL; Lara Y; Saavedra C; Strohmeyer M; Bartalesi F; Trigoso C; Rossolini GM
    Clin Microbiol Infect; 2013 Apr; 19(4):356-61. PubMed ID: 22414066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America.
    Pallecchi L; Bartoloni A; Fiorelli C; Mantella A; Di Maggio T; Gamboa H; Gotuzzo E; Kronvall G; Paradisi F; Rossolini GM
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2720-5. PubMed ID: 17548490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt.
    Hassan WM; Hashim A; Domany R
    Indian J Med Microbiol; 2012; 30(4):442-7. PubMed ID: 23183470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
    Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
    Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe.
    Jamborova I; Dolejska M; Vojtech J; Guenther S; Uricariu R; Drozdowska J; Papousek I; Pasekova K; Meissner W; Hordowski J; Cizek A; Literak I
    Appl Environ Microbiol; 2015 Jan; 81(2):648-57. PubMed ID: 25381245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q; Tian Y; Zhang L; Jiang C; Dong D; Li Z; Mao E; Peng Y
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):428-433. PubMed ID: 27681363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of β-lactamase and plasmid-mediated quinolone resistance genes in Escherichia coli isolated from farmed fish in China.
    Jiang HX; Tang D; Liu YH; Zhang XH; Zeng ZL; Xu L; Hawkey PM
    J Antimicrob Chemother; 2012 Oct; 67(10):2350-3. PubMed ID: 22809702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland.
    Seiffert SN; Hilty M; Kronenberg A; Droz S; Perreten V; Endimiani A
    J Antimicrob Chemother; 2013 Oct; 68(10):2249-54. PubMed ID: 23759671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.
    Briales A; Rodríguez-Martínez JM; Velasco C; de Alba PD; Rodríguez-Baño J; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2012 May; 39(5):431-4. PubMed ID: 22365240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases.
    Jones GL; Warren RE; Skidmore SJ; Davies VA; Gibreel T; Upton M
    J Antimicrob Chemother; 2008 Dec; 62(6):1245-51. PubMed ID: 18827034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru.
    Pallecchi L; Malossi M; Mantella A; Gotuzzo E; Trigoso C; Bartoloni A; Paradisi F; Kronvall G; Rossolini GM
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4556-61. PubMed ID: 15561825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of plasmid-mediated quinolone resistance determinants in chicken Escherichia coli isolates from 2001 to 2007.
    Huang SY; Dai L; Xia LN; Du XD; Qi YH; Liu HB; Wu CM; Shen JZ
    Foodborne Pathog Dis; 2009 Dec; 6(10):1203-9. PubMed ID: 19735206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Mendonça N; Leitão J; Manageiro V; Ferreira E; Caniça M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of a new group CTX-M enzyme in Romania and risk factors for extended spectrum beta-lactamase producing E. coli infections.
    Miftode E; Dorneanu O; Badescu A; Ghibu L; Leca D; Vremera T; Mereuţă A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):477-80. PubMed ID: 23077940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli with extended-spectrum β-lactamase and plasmid-mediated quinolone resistance genes in great cormorants and mallards in Central Europe.
    Tausova D; Dolejska M; Cizek A; Hanusova L; Hrusakova J; Svoboda O; Camlik G; Literak I
    J Antimicrob Chemother; 2012 May; 67(5):1103-7. PubMed ID: 22323500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital.
    Crémet L; Caroff N; Dauvergne S; Reynaud A; Lepelletier D; Corvec S
    Pathol Biol (Paris); 2011 Jun; 59(3):151-6. PubMed ID: 19481883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
    Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
    Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.